Letter #1 Response to letter to Editor by Dr. Sarkar et al. for’ who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for’ is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?’ Refers to PII: S2210-7789(21)00538-9

Detalles Bibliográficos
Autores principales: Jayaram, A., Buhimschi, I.A., Buhimschi, C.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716314/
https://www.ncbi.nlm.nih.gov/pubmed/34973599
http://dx.doi.org/10.1016/j.preghy.2021.11.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716314/
https://www.ncbi.nlm.nih.gov/pubmed/34973599
http://dx.doi.org/10.1016/j.preghy.2021.11.002

Ejemplares similares